Consistent with this, high prostatic 3β-HSD protein levels are correlated with several unfavorable clinical attributes in prostate cancer patients [30], while HSD3B2 transcript expression has been proposed as a potential prognostic biomarker in lung squamous cell carcinoma [31]. This evidence concerns the gene HSD3B2 and prostate carcinoma.